Company
IMX™ is pending regulatory approval to become a financial futures exchange for the healthcare industry. IMX™ will create a transparent, two sided market for pricing of health care assets, will provide hedging opportunities for payers and providers and other health care market participants and benefit patients through competition for services and through cushioning price shocks in the marketplace, leading to lower prices and premiums.
The Time is Now for a Futures Market in Health Care
Health care as an industry will experience explosive growth over the next two decades.
The entire health care industry needs access to the capital market tools available to other sectors of the economy.
Each of these have specific exposures to manage:
-
Insurers
-
Banks
-
Reinsurers
-
Investment Banks
-
Self-insured Companies
-
Hedge Funds
-
Pharma/Biotech
-
Registered Investment Advisors
-
Venture Capital
-
Futures Commission Merchants
-
Governments
-
Institutional Investors
-
Hospital Systems
-
Patients
Who Benefits from a Health Care Exchange? Everyone.
Health care is being revolutionized and we are moving from chronic treatment to episodic treatment and even cures.
Hepatitis C can be cured for $40,000 or less where previously it was treated as a chronic disease for which lifetime costs could reach $500,000.
Immunotherapies and gene therapies are very expensive and there will be many of them in the years to come.
The cost structure has completely changed but the way we pay the costs has not.
U.S. GDP is $20 trillion.
The Derivative markets facilitate risk management, price discovery and speculation. The notional value of derivatives is about $700 Trillion (forwards, futures, options, swaps).
Of that $700 trillion of derivatives, there are no derivatives for health care.
The Health care expenditure in the U.S. is approaching $4 Trillion (20% of GDP).
Largest derivatives exchanges worldwide in 2020,
by number of contacts traded (in millions)
